WishBone Featured in HSS Annual Report

WishBone is excited to be developing a pediatric total hip system with the Hospital for Special Surgery and to be featured in their annual report!

HSS

WishBone Medical, Inc. signs licensing agreement for the Guided Growth Plate

Warsaw, Indiana, December 14, 2018 – WishBone Medical, Inc. has been granted a global, non-exclusive license for the sale of a patented guided growth plating system in children with deformed limbs.  These 3 patents were created and designed for the gradual correction of pediatric deformities in both the upper and lower extremities.

WishBone Medical is designing and developing its own guided growth plate and instrumentation systems in sterile packed, single use, disposable kits.  This product will come in both the 2-hole and 4-hole plates systems in multiple sizes as well as options in stainless steel and titanium.  The anticipated launch will be in first quarter 2019, following FDA Clearance.

Nick Deeter, Chairman of the Board WishBone Medical, said, “We are excited to enter into this license agreement of patented technologies to develop, produce and sell our guided growth systems.  These systems will provide global access in sterile packed, single use disposable kits for children who are suffering with these pediatric deformities around the world.  Mr. Deeter added, “With this sterile packed system, we can go into hospitals and surgery centers that have not had access to the traditional reusable systems.”

Dr. Robert von Seggern, Executive Vice President at WishBone Medical, commented, “As a dedicated pediatric orthopedic company, WishBone Medical needed this product to round out its large portfolio of orthopedic implants designed specifically for children with orthopedic issues.”

About WishBone Medical, Inc.

WishBone Medical is a global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.  WishBone Medical currently has 42 pediatric orthopedic product systems with operations in Warsaw, IN, Istanbul, Turkey, and Singapore.

For further information, visit www.wishbone-medical-migration.mysites.io or call Mary Wetzel, Chief Operating Officer, at 574-306-4006.

WishBone Medical, Inc. acquires Response Ortho

Warsaw, Indiana, November 28, 2018 – WishBone Medical, Inc. announces the acquisition of Response Ortho. Response Ortho has a complete pediatric line of external and internal fixation and deformity correction products.

Response Ortho has been in business for fourteen years and has built a modern, high-tech manufacturing facility with access to an experienced engineering and technical labor force. Because of this, product development and launch activities have been dramatically accelerated for WishBone Medical with the Response Ortho offering of over thirty developed pediatric orthopedic systems, with multiple patents, including the award winning “Smart Correction” Hexapod Fixator and “Click2Correct” surgical preoperative planning software.  Eighteen of the current product systems can be sold in the US now and we are working on FDA clearance for the remaining products. Our commitment is to provide global access to anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits for children.

Nick Deeter, Chairman of the Board and CEO at WishBone Medical, said, “With the acquisition of Response Ortho, we are thrilled about our pediatric orthopedic product offerings. The combination of Response Ortho’s thirty product systems and WishBone’s eight product systems will give WishBone Medical the broadest product portfolio in pediatric orthopedics worldwide.”  Mr. Deeter added, “These pediatric orthopedic products can be delivered in sterile packed, procedural kits anywhere in the world, next day, to the surgeons that care for children.”

Sehmuz Isin, CEO of Response Ortho said, “We are excited that Response Ortho is now part of WishBone Medical.  Our primary focus has been outside the US, and we will now be able to offer these innovative orthopedic product systems everywhere.  Having more than 50 years of combined experience, Nick and I understand the unmet needs and will provide global solutions to children with orthopedic issues.”

About WishBone Medical, Inc.

WishBone Medical is a Global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.

About Response Ortho

Response Ortho is a vertically integrated, ISO 13485 certified, CE Mark lean company that is focused on the orthopedic industry with modern equipment and scalable technology. Response Ortho is located in Istanbul, Turkey.

For further information, visit www.wishbone-medical-migration.mysites.io or call Andrew Miclot, Vice-Chairman and President at 574-306-4006.

WishBone Medical, Inc. announces the acquisition of Red Star Contract Manufacturing to provide sterile-packed kits for the pediatric orthopedic market

Warsaw, Indiana, November 6, 2018 – WishBone Medical, Inc. and Red Star Contract Manufacturing have teamed up to provide sterile packaging and plastic injection molded single use instrument capabilities for their pediatric orthopedic market. WishBone Medical is committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits for their surgeons, hospitals, and customers worldwide. Red Star Contract Manufacturing is a leader in injection molded disposable instruments for the medical device industry as well as having a fully functional sterile packaging clean room and fulfillment center.

Nick Deeter, Chairman of the Board and CEO at WishBone Medical, said, “We believe that single use, disposable kits are the future for orthopedics. Red Star can grow as WishBone Medical grows to provide these single use pediatric orthopedic products for kids.” Mr. Deeter added, “With this vertical integration of Red Star, we can insure we have access to this very important part of our supply chain.”

Scott Werstler, President of Red Star Contract Manufacturing, said, “We are excited Red Star is part of the WishBone Medical team providing these sterile packed products to help kids with orthopedic issues world-wide.  Because of our work with WishBone Medical in completing all the sterilization validation and tooling for the most common instruments, Red Star will be able to provide other OEM’s a turn-key solution to sterile-packed implants and instrumentation.  We know the future of orthopedics is sterile packed single use products, like the rest of the healthcare industry, and we are well equipped and have the capacity to support it.”

About WishBone Medical, Inc.

WishBone Medical is a Global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.

For further information, visit www.wishbone-medical-migration.mysites.io or call Andrew Miclot, Vice-Chairman and President at 574-306-4006.

About Red Star Contract Manufacturing

Red Star Contract Manufacturing is a vertically integrated, ISO 13485 certified, lean company that is focused on the medical device industry with an expertise in insert injection molding, Class 8 clean room packaging, sterilization, and fulfillment. Red Star is located just outside Warsaw in Larwill, Indiana.

For further information, visit www.redstarcontractmfg.com or call Scott Werstler, President at 260-327-3145.

WishBone Medical, Inc. announces new AlloMate Bone Pin System

The AlloMate Bone Pin System consists of allograft bone pins and accessory instrumentation for quick, reliable and reproducible bone pin insertion.  The complete system will be available in five different individual sizes (2.0mm, 2.5mm, 3.0mm, 3.5mm, and 4.0mm) of sterilized human cortical bone pins & corresponding single-use instruments for convenient insertion. We will launch these various sizes in stages. The 3.0mm is currently available and the 2.5mm will be available soon followed by the 2.0mm and the additional sizes. Our initial market feedback with the 3.0mm system has been extremely positive.

These bone pins are sturdy, easy to handle and can integrate into the patient’s bone to help with the healing process. These sterile packed implants and instruments may potentially reduce the risk of infection and can be accurately trimmed intraoperatively to an appropriate length.

Daniel S. Schulman, D.P.M., helped develop this system and he said, “I have performed well over four hundred foot reconstructive procedures without the use of a metal implant.  I can validate that this system will definitely simplify the surgical technique and minimize intra-operative and post-operative surgical complications. Patients are elated when they are told there will be no need for a second surgery to remove potentially painful, broken or even infected hardware.”

Nick Deeter, Chairman of the Board and CEO at WishBone Medical, said, “The AlloMate Bone Pin System does help minimize the need for removal in a secondary operation to remove hardware like stainless steel wires.” Mr. Deeter added, “Minimizing the number or surgeries for kids is very important to us.”

About WishBone Medical, Inc.

WishBone Medical is a Global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.

For further information, email CustomerService@wishbonemedical.com or call at 574-306-4006. To learn more about WishBone Medical visit www.wishbone-medical-migration.mysites.io or contact Andrew Miclot, Vice-Chairman and President.

WishBone Medical, Inc. announces Sanford S. Kunkel, M.D. joins Board of Advisors

Warsaw, Indiana, July 12, 2018 – WishBone Medical, Inc. is pleased to announce that Sanford Kunkel, M.D. joins the WishBone Medical Board of Advisors. Dr. Kunkel has been a consulting surgeon for WishBone Medical helping to develop several new innovative products and will continue in this role.  As a member of the Board of Advisors, he will be a part of an elite group of business people from around the world to provide strategic expertise and guidance for WishBone Medical. He is considered an expert in his field and was a team physician for the Indiana Pacers, Indiana Fever, USA Basketball, DePauw University and Brebeuf Jesuit Preparatory school.

He has been a practicing physician at OrthoIndy for over 30 years. OrthoIndy is one of the largest orthopedic practices in the world.  Dr. Kunkel consults for several healthcare companies and has developed several successful products.

Dr. Kunkel earned his Bachelor’s Degree from Indiana University and his medical degree from the Indiana University School of Medicine. He did his internship at St. Mary’s Hospital in Grand Rapids, MI. and his residency at Grand Rapids Orthopedic Surgery and Blodgett Memorial Medical Center. His fellowship was in Sports Medicine at the University of Toronto and at the University of Western Ontario in London, Ontario. He is certified by the American Board of Orthopaedics.

Nick Deeter, Chairman of the Board and CEO at WishBone Medical, said, “Dr. Kunkel brings his surgeon skills and entrepreneurial background to the WishBone Medical Board of Advisors. We look forward to working with Dr. Kunkel to not only develop successful pediatric products but also to help strategically guide WishBone Medical. Mr. Deeter added, “With his extensive background and experience, he will contribute to our mission of helping children globally with orthopedic issues.”

 

About WishBone Medical, Inc.

WishBone Medical is a global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single-use, disposable kits to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.

For further information, visit www.wishbone-medical-migration.mysites.io or call Andrew Miclot, Vice-Chairman and President at 574-306-4006.

WishBone Medical, Inc. announces Randal R. Betz, M.D. as Chief Medical Officer

Warsaw, Indiana, June 20, 2018 — WishBone Medical, Inc. is pleased to announce the appointment of Randal R. Betz, M.D. as Chief Medical Officer. Dr. Betz, on a part time consulting basis, will provide strategic expertise and guidance for the company’s product portfolio, support professional education and help with key opinion leader relationships consistent with WishBone Medical’s objectives.

Dr. Betz earned a Medical Degree from Temple University School of Medicine. His internship in general surgery and residency in orthopaedics was at Temple University Hospital. Dr. Betz completed his fellowship in Pediatric Orthopaedics from the Alfred I duPont Institute. He is a pediatric orthopedic surgeon with a focus on pediatric deformity correction.

He formerly was Chief of Staff at Shriners Hospitals for Children in Philadelphia. His current positions include a private practice at the Institute for Spine and Scoliosis in Lawrenceville, NJ, Clinical professor at Mount Sinai Medical Center in New York City and attending surgeon at Mount Sinai Hospital in New York City and Saint Peter’s Children’s University Hospitals in New Brunswick, NY.

Research and product development is important to Dr. Betz, and he also has 17 patents. He belongs to several national and international professional societies. He has published 5 books, authored many medical texts and books; including 52 chapters for medical books and written 330 peer-reviewed articles.

Nick Deeter, Chairman of the Board and CEO at WishBone Medical, said, “We look forward to working with Dr. Betz on pediatric orthopedic products designed just for kids. He is well known and respected for his pediatric orthopedic expertise around the world.” Mr. Deeter added, “With his extensive background and experience, he will help build our surgeon teams and focus our strategic direction on helping children globally with orthopedic issues.”

About WishBone Medical, Inc.

WishBone Medical is a global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.

For further information, visit wishbone-medical-migration.mysites.io or call Andrew Miclot, Vice-Chairman and President at 574-306-4006.

WishBone Medical, Inc. and Hospital for Special Surgery (HSS) Collaborate to Develop a Novel Pediatric Total Hip Implant

NEW YORK, NY, March 07, 2018 – WishBone Medical, Inc., a new global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants, entered into a license agreement with the global leader in orthopedic surgery, Hospital for Special Surgery (HSS), for the development of a novel Pediatric Total Hip. The system will be developed to address treatment of juvenile idiopathic arthritis (JIA) patients or young patients with congenital dysplastic hip (CDH) disease.

“We look forward to working with HSS on a Pediatric Total Hip system designed just for kids,” said Nick Deeter, Chairman of the Board and CEO at WishBone Medical; “HSS is the premier musculoskeletal hospital in the world and their expertise and collaboration will be invaluable to develop this technology.”

“HSS’s clinical leadership, biomechanical engineering and innovation expertise together with Wishbone’s experience developing technologies to serve pediatric patients, position us to improve the quality of life of these young patients who do not have many therapeutic options,” said Louis A. Shapiro, president and CEO of HSS. “As an inventor of these technologies, Dr. Mark Figgie, our Chief of the Surgical Arthritis Service at HSS is a leading expert in the field, who along with our biomechanical engineers have a long history in both treating and innovating for this patient population.” Shapiro added.

###

About WishBone Medical, Inc.

WishBone Medical is a Global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing. To learn more about WishBone Medical, visit www.wishbone-medical-migration.mysites.io

For more information, please call Andrew Miclot, Vice-Chairman and President at 574-306-4006 or email CustomerService@wishbonemedical.com.

About HSS | Hospital for Special Surgery

HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients from 80 countries and performed more than 32,000 surgical procedures. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Innovation Institute was formed in 2015 to realize the potential of new drugs, therapeutics and devices; the global standard total knee replacement was developed at HSS in 1969, and in 2017 HSS made 130 invention submissions (more than 2x the submissions in 2015). The HSS Education Institute provides continuing medical curriculum to more than 15,000 subscribing musculoskeletal healthcare professionals in 110 countries. Through HSS Global, the institution is collaborating with medical centers worldwide to advance the quality and value of care and to make world-class HSS care more accessible to more people.

WishBone Medical, Inc. entered into a U.S. distribution agreement with Implanet

Warsaw, Indiana, March 6, 2018 – WishBone Medical. Inc. entered into a U.S. distribution agreement with Implanet to distribute the JAZZ implant system to treat spinal pathologies requiring vertebral fusion surgery in the Orthopedic Market.

The first procedure with WishBone Medical surgeons was completed in early 2018. “We are looking forward to expanding our Orthopedic spine products and the JAZZ system is our first product in this market,” said Nick Deeter, Chairman of the Board and CEO at WishBone Medical.

Mr. Deeter added, “WishBone Medical provides innovative implants and instruments in sterile packed, single use disposable kits and the JAZZ implant system is available in these single use kits.”

Ludovic Lastennet, CEO of Implanet said, “This disruptive single use, sterile packed business model of WishBone Medical compliments the Implanet America JAZZ platform of single use, sterile packed products.”

To learn more about WishBone Medical, visit www.wishbone-medical-migration.mysites.io

About WishBone Medical, Inc.

WishBone Medical is a Global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.

For further information, visit www.wishbone-medical-migration.mysites.io or call Andrew Miclot, Vice-Chairman and President at 574-306-4006.

About IMPLANET

Founded in 2007, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery. Its flagship product, the JAZZ® latest-generation implant, aims to treat spinal pathologies requiring vertebral fusion surgery. Protected by four families of international patents, JAZZ® has obtained 510(k) regulatory clearance from the Food and Drug Administration (FDA) in the United States and the CE mark. IMPLANET employs 48 staff and recorded 2017 sales of €7.8 million. For further information, please visit www.implanet.com.

Based near Bordeaux in France, IMPLANET established a US subsidiary in Boston in 2013.

IMPLANET is listed on Euronext™ Growth market in Paris. ALIMP

To learn more about IMPLANET, visit www.Implanet.com

Please contact WishBone Medical at 574-306-4006 or email CustomerService@wishbonemedical.com for more information. To learn more about WishBone Medical, visit www.wishbone-medical-migration.mysites.io

WishBone Medical’s response to OrthoPediatrics press release

Warsaw, Indiana, January 3, 2019 – “Both the motion and OrthoPediatrics’ case as a whole are without merit and OP knows it.  OP is merely trying to use this litigation to bully WishBone Medical by trying to outspend us on lawyers.  We have new, innovative, and better orthopedic products for kids.  We know it; they know it.  It’s really that simple.  But OP sees this as a threat to their profits, so they are trying to use the litigation process to hamper and spy on WishBone.  It’s dishonorable; and it won’t work.  We are very confident in our case and we will be asking the court for a trial date as soon as available so that we can put an end to OP’s anti-competitive and cowardly tactics,” said Nick Deeter, CEO of WishBone Medical.

WishBone Medical, Inc. is a pediatric orthopedic company dedicated to the unmet needs of children suffering from orthopedic challenges. Our commitment is to provide global access to anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits.  WishBone was started two years ago by Nick Deeter and has been called by OrthoStreams “the undisputed pioneer of orthopedic implants for kids.”  Nick Deeter was also the founder of OrthoPediatrics, which he started in 2006. Nick is deeply saddened in the way he is being treated by his former company.

Nick Deeter welcomes competition.  In a recent interview, Nick commented “We are operating in a $2.5 billion market where 95% of the implants were not designed for children.  It’s an appalling statistic…I would welcome the competition to improve outcomes for children.”  Sadly, this legal campaign by OP is designed to eliminate fair competition while doing nothing to promote improved outcomes for children.

WishBone fully expects to be vindicated in this lawsuit.  We look forward to having it behind us so that we can continue to build our company.  We have recently announced the acquisition of Red Star Contract Manufacturing (sterile packaging and injection molding), Response Ortho (an orthopedic company with 34 product systems in operation since 2004), and a licensing agreement for a guided growth plate.  With these acquisitions, WishBone will have the most complete line of pediatric orthopedics in the industry and our line will have the added benefit of being sterile packed.  It is a winning combination that will ultimately lead to our market win, and more importantly, provide better access for children’s orthopedic needs.

About WishBone Medical, Inc.

WishBone Medical is a global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.  WishBone Medical currently has 42 pediatric orthopedic product systems with operations in Warsaw, IN, Istanbul, Turkey, and Singapore.

For further information, visit www.wishbone-medical-migration.mysites.io or call Mary Wetzel, Chief Operating Officer, at 574-306-4006.